SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)

SS Innovations International's (SSII) quarterly Cash from Financing Activities came in at $18.2 million in Q1 2026, down 18.95% year-on-year from $22.4 million in Q1 2025, and up 1222.47% quarter-over-quarter from $1.4 million in Q4 2025.

SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends

SS Innovations International has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $18.2 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $18.2 million, down 18.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.9 million (down 24.91% YoY), and the FY2025 annual result was $26.2 million, up 177.6% from the prior year.
  • Cash from Financing Activities came in at $18.2 million for Q1 2026 at SS Innovations International, up from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.4 million in Q1 2025 to a low of -$702098.0 in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $2.7 million (2024), against an average of $5.4 million.
  • Across the five-year window, Cash from Financing Activities surged 15516.71% in 2022 and sank 126.45% in 2025, its largest moves.
  • SS Innovations International's Cash from Financing Activities stood at $3.1 million in 2022, then slumped by 95.1% to $150563.0 in 2023, then jumped by 2165.52% to $3.4 million in 2024, then slumped by 59.74% to $1.4 million in 2025, then jumped by 1222.47% to $18.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at $18.2 million (Q1 2026), $1.4 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn 18.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.16 Mn
Mar 31, 2026 18.16 Mn
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 3.09 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 -702,098.00
Jun 30, 2025 -702,098.00
Mar 31, 2025 22.41 Mn
Mar 31, 2025 22.41 Mn
Dec 31, 2024 3.41 Mn
Dec 31, 2024 3.41 Mn
Sep 30, 2024 722,336.00
Sep 30, 2024 722,336.00
Jun 30, 2024 2.65 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 2.64 Mn
Mar 31, 2024 2.64 Mn
Dec 31, 2023 150,563.00
Dec 31, 2023 150,563.00